VFA
EPZM

Virtus Fund Advisers’s Epizyme, Inc EPZM Stock Holding History

Virtus Fund Advisers’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$346K Buy
+27,541
New +$400K ﹤0.01% 414
2014
Q3 		– Sell
-1,092
Closed -$34K – 2117
2014
Q2 		$34K Buy
+1,092
New +$25.7K ﹤0.01% 2116

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Virtus Fund Advisers's EPZM Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Epizyme, Inc (EPZM) in Q4 2017: 27,541 shares worth $346K. The stake represents ﹤0.01% of the portfolio and ranks #414 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in EPZM as recently as Q2 2014.

Virtus Fund Advisers first reported a position in EPZM in Q2 2014 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold EPZM as of Q4 2017.

  • Virtus Fund Advisers held 27,541 shares of Epizyme, Inc worth $346K as of Q4 2017.
  • Epizyme, Inc was a new Virtus Fund Advisers position in Q4 2017.
  • Epizyme, Inc made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #414 holding.
  • Virtus Fund Advisers first reported a position in Epizyme, Inc in Q2 2014 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.